RIBOLIFE-B (06938) has been included in the Hang Seng Composite Index constituents and added to the list of stocks eligible for the Hong Kong Stock Connect.

RIBOLIFE-B (06938) announced that, according to an announcement by Hang Seng Indexes Company Limited, the company's shares have been included in the Hang Seng Composite Index component stocks, and they are also included in the list of eligible securities for the southbound trading of the Stock Connect (Hong Kong Stock Connect), effective from September 7, 2026. The inclusion of the company's shares in the Hang Seng Composite Index and the Hong Kong Stock Connect is a significant milestone in the company's development in the capital market. It also represents an important step for the company to deeply integrate into the China mainland and international capital markets and to commit to serving the high-quality development strategy of the national biopharmaceutical industry. This fully reflects the capital market's high recognition of the company's performance, core value, corporate governance standards, and development potential. Following the implementation of the Hong Kong Stock Connect, it is expected to significantly improve the liquidity of the company's shares, expand the investor base, further optimize the shareholder structure, and enhance market attention and influence in the capital market.